Warfarin-Rifampin Drug Interaction in a Pediatric Patient.
暂无分享,去创建一个
B. Moffett | D. Yee | M. Poon
[1] A. Rettie,et al. P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms , 2015, Drug Metabolism and Disposition.
[2] L. Bomgaars,et al. Readmissions for warfarin‐related bleeding in pediatric patients after hospital discharge , 2013, Pediatric blood & cancer.
[3] S. Pastakia,et al. Describing the Profile of Patients on Concurrent Rifampin and Warfarin Therapy in Western Kenya: A Case Series , 2013, Drugs in R&D.
[4] N. Holford,et al. Understanding dosing: children are small adults, neonates are immature children , 2013, Archives of Disease in Childhood.
[5] L. Bomgaars,et al. Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients , 2012, Pediatric blood & cancer.
[6] S. Vesely,et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[7] Kristin C. Krajewski. Inability to Achieve a Therapeutic INR Value While on Concurrent Warfarin and Rifampin , 2010, Journal of clinical pharmacology.
[8] John R Horn,et al. Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.
[9] Craig R. Lee,et al. Difficulties in Anticoagulation Management during Coadministration of Warfarin and Rifampin , 2001, Pharmacotherapy.
[10] P. Casner. Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited. , 1996, Southern medical journal.